Adtralza 300 mg/2 mL

Adtralza 300 mg/2 mL is a medicine authorised by Swissmedic under authorisation number 70277. The authorisation holder is Leo Pharmaceutical Products Sarath Ltd.. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 February 2026 and the authorisation is limited until 04 February 2031. ATC code D11AH07 places the medicine in the group Other dermatological preparations.

  • Dispensing category B
  • Authorisation number 70277
  • ATC D11AH07
  • Biotechnological medicines
Authorisation data
Authorisation number70277
NameAdtralza 300 mg/2 mL
Full nameAdtralza 300 mg/2 mL, Injektionslösung im Fertigpen
Authorisation holderLeo Pharmaceutical Products Sarath Ltd.
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeD11AH07
First authorisation05 February 2026
Authorisation validity04 February 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Adtralza 300 mg/2 mL, Injektionslösung im FertigpenB05 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12 x 2mlD11AH0707.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Adtralza 300 mg/2 mL authorised in Switzerland?

Yes. Adtralza 300 mg/2 mL is authorised by Swissmedic under authorisation number 70277, data as of 01 September 2026. The authorisation is limited until 04 February 2031.

Which dispensing category does Adtralza 300 mg/2 mL have?

Adtralza 300 mg/2 mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Adtralza 300 mg/2 mL?

The authorisation holder is Leo Pharmaceutical Products Sarath Ltd.. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com